The VRBPAC will meet in open session on 28 June 2022 to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified. FDA intends to make
The purpose of this meeting is to gather feedback from stakeholders about their experiences implementing these policies, the effect of these policies in terms of achieving their stated goals, the
The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are co-sponsoring this public virtual workshop on August 30, 2022. All meeting materials—including agenda, panelist affiliations/disclosures,
The 21st Presidential Advisory Council on Combating Antibiotic Resistant Bacteria (PACCARB) public meeting is tentatively being planned as an in-person event on September 12 and September 13, 2022. The meeting
The Scientific Advisory Committee on Alternative Toxicological Methods will meet 21-22 September 2022. This is a Save-the-Date posting. Further details will be made available at the National Toxicology Program website
The U.S. Food and Drug Administration (FDA) will host a virtual town hall for monkeypox test developers on 21 September 2022. The purpose of these town halls is to help
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) will convene on 22 September 2022 to discuss the Biologics License Application # 125739 (BLA - 125739) from Rebiotix Inc. for
Hear insights and information from APHIS and other experts on steps to take and what to expect during a bird flu outbreak during a free webinar on 22 September 2022.
The 5th Annual Meeting of the FDA/National Center for Toxicological Research (NCTR) – Massive Analysis and Quality Control Society (MAQC) 2022 Conference will be held September 26-27, 2022, at the
